Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EAST RUTHERFORD, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, will release financial...
-
POWR’s recent lithium discovery is an amazing advancement and CEO Matt Chatterton Schedules Special Investor Announcement.
-
TARRYTOWN, NY, Oct. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nightfood Holdings, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snack category, announced today that...
-
LENEXA, Kansas, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for the second quarter 2023. An investor...
-
Q2 2023 Interim Report and Investor Conference Call Announcement Welltec® will disclose its Q2 2023 Interim Report and will discuss the results during an investor conference call to be held...
-
Q1 2023 Interim Report and Investor Conference Call Announcement Welltec® will disclose its Q1 2023 Interim Report and will discuss the results during an investor conference call to be held Tuesday,...
-
LENEXA, Kansas , April 03, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for 2022. An investor conference call is...
-
Digital Ally to Discuss Year-End Results, Status of Previously Announced Corporate Spin-Off, and Individual Subsidiary Outlooks. KANSAS CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc....
-
CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
-
CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...